Lucy Scientific Discovery Cash Flow Statement

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Year	2023	2022	2021
Net Income	-8.99	-5.86	-4.73
Depreciation & Amortization	0.1	0	0
Share-Based Compensation	0.17	0.21	0.97
Other Operating Activities	4.45	3.23	2.27
Operating Cash Flow	-4.27	-2.42	-1.48
Change in Investments	0.03	-0.03	0
Other Investing Activities	-0.3	-	-
Investing Cash Flow	-0.27	-0.03	0
Share Issuance / Repurchase	7.5	0.04	0.77
Debt Issued / Paid	0.13	2.83	0.99
Other Financing Activities	-1.44	-0.62	-0.06
Financing Cash Flow	6.19	2.25	1.7
Exchange Rate Effect	-0.04	0.01	-0.02
Net Cash Flow	1.62	-0.19	0.2
Free Cash Flow	-4.27	-2.42	-1.48
Free Cash Flow Margin	-60532.82%	-	-
Free Cash Flow Per Share	-3.36	-2.81	-2.77

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).